Peter Foley to Quality of Life
This is a "connection" page, showing publications Peter Foley has written about Quality of Life.
Connection Strength
0.031
-
Strober B, Tada Y, Mrowietz U, Lebwohl M, Foley P, Langley RG, Warren RB, Wang M, Vanvoorden V, Szilagyi B, Ciaravino V, Paul C. Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial. Br J Dermatol. 2023 05 24; 188(6):749-759.
Score: 0.031